Ali Rizvi to Biomarkers
This is a "connection" page, showing publications Ali Rizvi has written about Biomarkers.
Connection Strength
0.504
-
Cytokine biomarkers, endothelial inflammation, and atherosclerosis in the metabolic syndrome: emerging concepts. Am J Med Sci. 2009 Oct; 338(4):310-8.
Score: 0.222
-
Novel molecular markers of cardiovascular disease risk in type 2 diabetes mellitus. Biochim Biophys Acta Mol Basis Dis. 2021 08 01; 1867(8):166148.
Score: 0.124
-
Inflammation markers as mediators of vasculo-endothelial dysfunction and atherosclerosis in the metabolic syndrome. Chin Med J (Engl). 2007 Nov 05; 120(21):1918-24.
Score: 0.049
-
The role of inflammation in diabetes and its complications. South Med J. 2006 Jan; 99(1):8-9.
Score: 0.043
-
Genetic and Epigenetic Biomarkers for Diagnosis, Prognosis and Treatment of Metabolic Syndrome. Curr Pharm Des. 2021; 27(35):3729-3740.
Score: 0.030
-
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study. Cardiovasc Diabetol. 2016 Dec 03; 15(1):162.
Score: 0.023
-
The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance? Acta Diabetol. 2009 Mar; 46(1):1-11.
Score: 0.013